Amerique Du Nord S.n.c. Sanofi-Aventis is 10% at REGENERON PHARMACEUTICALS INC (REGN). They have made 1 open-market trade across 1 company since 2010, most recently 2010-10-13.
CIK 0001421144
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $28.5M since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| REGN | 15,816,953 | $12.5B |
Shares reported on the most recent Form 4, priced at the 2010-10-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REGN | BUY | 2010-10-13 | 2010-10-14 | $28.00 | $28.5M | -13.6% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.